• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM; RENAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM; RENAL STENT SYSTEM Back to Search Results
Catalog Number 1011528-18
Device Problems Difficult To Position (1467); Unstable (1667)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/06/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Evaluation summary: (b)(4).The device was returned for evaluation and the reported resistance was unable to be confirmed due to the condition of the returned device.The stent implant was not returned.Based on visual analysis, there is no indication of a product quality issue with respect to manufacture, design, or labeling.The investigation determined that the reported resistance and partial stent dislodgment appear to be related to case circumstances.A review of the lot history record revealed no non-conformances.A query of the electronic complaint handling database revealed no other incidents reported from this lot.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event Description
It was reported that the procedure was performed to treat a lesion in the renal artery.The 5.0 x 18 mm herculink stent delivery system (sds) was advanced, but was not tracking through the 6f sheath.The sds was removed and attempted again, but during advancement, met resistance half way through the sheath.The sds was replaced with a non-abbott sds, and the procedure was completed successfully.There was no resistance felt during withdrawal of herculik sds.There were no adverse patient effects and no clinically significant delay in the procedure.Returned device analysis found that the stent was dislodged from the sds.Further information from the account reported that after removal, a small portion of the stent was deployed [partially dislodged].During packaging for return, the stent was removed from the sds and discarded.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
RENAL STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key5131636
MDR Text Key27941550
Report Number2024168-2015-05887
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Report Date 10/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2015
Device Catalogue Number1011528-18
Device Lot Number2080861
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/16/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-